Jobs

Currently 3879 jobs

Candidates Login

CV Database

Let the jobs come to you!

Company Login

Site Newsletter

Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

PharmiWeb on Facebook

Advertising

Press Releases

submit a press release

75 Press Releases

1 2 3

Date	Title	Company
15 Apr 13	BioAlliance Pharma’s Sitavig® Receives Market Authorization in the US For the Treatment of Herpes Labialis	BioAlliance Pharma, Published by Business Wire
12 Mar 13	BioAlliance Pharma Pursues the Development Plan of Its Loramyc® in Japan Through Its Partner Sosei	BioAlliance Pharma, Published by Business Wire
28 Feb 13	BioAlliance Pharma Signs a Collaborative Agreement with One of the Worldwide Leaders in Vaccines for a Vaccine Application of Its Patented Lauriad® Mucoadhesive Technology	BioAlliance Pharma SA, Published by Business Wire
14 Feb 13	BioAlliance Pharma announces the forthcoming extension of its phase II clinical trial with Validive® in the United States	BioAlliance Pharma SA, Published by Business Wire
07 Jan 13	BioAlliance Pharma Announces the Launch of Oravig® in the United States by Its New Partner, Vestiq Pharmaceuticals	BioAlliance Pharma SA, Published by Business Wire
03 Jan 13	BioAlliance Pharma receives a guarantee from Coface to finance its export activities	BioAlliance Pharma SA, Published by Business Wire
21 Dec 12	BioAlliance Pharma Announces the Registration of Sitavig® in European Countries	BioAlliance Pharma, Published by Business Wire
20 Dec 12	BioAlliance Pharma: First Meeting of the DSMB of the ReLive Trial and Continuation without Modification of the Phase III Clinical Trial with Livatag® in Primary Liver Cancer	BioAlliance Pharma, Published by Business Wire
06 Dec 12	BioAlliance Pharma: First meeting of the DSMB of the ReLive trial and continuation without modification of the Phase III clinical trial with Livatag® in primary liver cancer	BioAlliance Pharma SA, Published by Business Wire
14 Nov 12	BioAlliance Pharma SA: Quarterly information as of September 30, 2012	BioAlliance Pharma SA, Published by Business Wire
18 Oct 12	BioAlliance Pharma: New agreement signed for the distribution of Loramyc® in Iran with Shafayab Gostar	BioAlliance Pharma SA, Published by Business Wire
01 Oct 12	BioAlliance Pharma SA: Presentation of Phase I clinical results with AMEP® biotherapy in the treatment of metastatic melanoma	BioAlliance Pharma SA, Published by Business Wire
24 Sep 12	BioAlliance Pharma announces the execution of its licensing agreement with Vestiq Pharmaceuticals for Oravig® in the US	BioAlliance Pharma, Published by Business Wire
13 Sep 12	BioAlliance Pharma : Key milestones and consolidated accounts for the first semester of 2012	BioAlliance Pharma SA, Published by Business Wire
26 Jul 12	BioAlliance Pharma announces the grant of US patent covering Sitavig®	BioAlliance Pharma SA, Published by Business Wire
19 Jul 12	BioAlliance Pharma announces a license agreement on Oravig® In the United States with Vestiq Pharmaceuticals	BioAlliance Pharma SA, Published by Business Wire
12 Jul 12	BioAlliance Pharma extends and strengthens the protection of AMEP® with the grant of two patents in the US	BioAlliance Pharma SA, Published by Business Wire
02 Jul 12	BioAlliance Pharma: Progress in the development of Loramyc® in Japan towards its registration by the partner Sosei	BioAlliance Pharma SA, Published by Business Wire
18 Jun 12	BioAlliance Pharma Reinforces Its Development Team with the Appointment of Louis Kayitalire, MD, as Head of Research and Development	BioAlliance Pharma, Published by Business Wire
13 Jun 12	BioAlliance Pharma and Teva Announce First License Agreement for Sitavig® for Israel	BioAlliance Pharma, Published by Business Wire
01 Jun 12	BioAlliance Pharma: Combined Shareholders Meeting	BioAlliance Pharma, Published by Business Wire
29 May 12	BioAlliance Pharma SA : Receivability of Sitavig® US Registration Dossier (NDA) for the Treatment of Recurrent Orofacial Herpes Validated by the FDA	BioAlliance Pharma SA, Published by Business Wire
14 May 12	BioAlliance Pharma SA: Initiation of ReLive, phase III clinical trial with Livatag® In primary liver cancer	BioAlliance Pharma SA, Published by Business Wire
26 Apr 12	BioAlliance Pharma Announces Two New Key Steps in the Development of Its AMEP® Biotherapy	BioAlliance Pharma, Published by Business Wire
18 Apr 12	BioAlliance Pharma: Full-Year Financial Results for 2011	BioAlliance Pharma, Published by Business Wire
17 Apr 12	BioAlliance Pharma Announces: New Achievements in Clonidine Lauriad™ Clinical Development, Second Product of Its Orphan Oncology Portfolio	BioAlliance Pharma SA, Published by Business Wire
21 Mar 12	BioAlliance Pharma: Success of the first BioAlliance Pharma’s symposium « Oncology: key issues for the future »	BioAlliance Pharma SA, Published by Business Wire
01 Feb 12	To Gain a Better Understanding of the Company, Its Product Portfolio and Its Management Team, BioAlliance Pharma Organizes a Symposium "Oncology: Key Issues for the Future"	BioAlliance Pharma, Published by Business Wire
26 Jan 12	2011 Achievements and 2012 Prospects BioAlliance Pharma Confirms the Dynamics of Its Core Business	BioAlliance Pharma, Published by Business Wire
23 Jan 12	BioAlliance Pharma Announces Two Key Steps with Its AMEP™ Biotherapy for Metastatic Melanoma	BioAlliance Pharma, Published by Business Wire

1 2 3

subscribe in a reader

Advertising

Share | | |

Site Map
Privacy & Security
Cookies
Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.